Philips Teams Up with German Startup Onelife Health to Expand its Digital Health Services in Mother and Child Care

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a partnership agreement with German digital health company Onelife Health to jointly develop innovative connected health solutions around mother and child care. Leveraging synergies between the portfolios of the two companies in this important area of consumer health, the partnership will initially focus on developing Onelife's Femisphere pregnancy and first-year-of-life guidance app. As part of the agreement, Philips has acquired a minority interest in Onelife Health.

"We see great potential to leverage the synergies between Philips' and OneLife Health's digital services for expectant mothers and their babies, so that we can improve and expand their use," said Bernd Laudahn, Market Leader Philips Personal Health DACH. "Onelife's ideas fit perfectly with our own mission to improve people's lives through meaningful innovations, and helping to safeguard the health of mothers and their babies during pregnancy, birth and the first years of life is a very important part of it."

"We are very pleased to be teaming up with a company that has a global footprint and extensive experience in the health technology industry, which will enable us to significantly accelerate our growth," said David Schaerf, CEO of Onelife Health. "By partnering with Philips, and working together with its experts in consumer health and professional healthcare, we aim to expand the depth and reach of our products."

Using Onelife's Femisphere app, expectant mothers can track vital signs such as their weight and blood pressure, plus other information such as their exercise levels, sleep quality and mood. The app automatically detects relevant changes and interdependencies in the data in order to provide real-time feedback, such as whether it might be advisable to contact a medical professional. Identifying potential risks and complications at an early stage of pregnancy offers greater security for the health of both mother and child.

By subscribing to Onelife’s Intouch service, Femisphere users will be able to digitally share data with their medical professionals so that situations can be rapidly assessed and any necessary intervention initiated. Intouch also provides doctors and midwives with a platform for proactively accessing relevant patient data and test results, so they can directly contact their patients to offer advice or schedule appointments.

OneLife will complement the capabilities of Philips uGrow, which is specifically designed to help parents give their children the best start in life. Philips uGrow captures data from connected devices such as Philips' smart baby monitor and smart ear thermometer, combines it with manually entered information such as feeding and sleeping patterns, and provides personalized feedback, advice on what to expect, and assurance that development is on track.

"As a global leader in mother and child care, we are continually looking at new ways to enhance the Philips uGrow platform and Onelife will enable us to help parents make better informed parenting decisions," said Egbert van Acht, Business Group Leader Health & Wellness at Philips. "While the collaboration with Onelife will initially focus on Germany, Philips’ largest market in Europe, our goal is of course to introduce the new propositions in other countries as well."

The uGrow ecosystem is built on the open infrastructure of Philips HealthSuite - a cloud-enabled connected health ecosystem of devices, apps and digital tools that work seamlessly together to empower personalized health and continuous care. HealthSuite is purpose-built to benefit consumers, patients and populations across the health continuum, from healthy living and prevention to diagnosis, treatment and home care.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 71,000 employees with sales and services in more than 100 countries.

Most Popular Now

AI Points the Way to Better Doctor-Patie…

A computer analysis of hundreds of thousands of secure email messages between doctors and patients found that most doctors use language that is too complex for their patients to understand...

Open Call DIGITAL-2021-DEPLOY-01-TWINS-H…

The development of digital twins in healthcare (DTH) has progressed substantially, profiting from advances in science and technology. In order to exploit their benefits in view of better prevention approaches...

Mayo Clinic Researchers Use AI, Biomarke…

Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients...

Mjog by Livi Launches Remote Monitoring …

Mjog by Livi has launched a remote monitoring tool that will help GPs support and monitor people with depression through messages sent to their smartphones. The latest data from the Office...

Could EKGs Help Doctors use AI to Detect…

Pulmonary embolisms are dangerous, lung-clogging blot clots. In a pilot study, scientists at the Icahn School of Medicine at Mount Sinai showed for the first time that artificial intelligence (AI)...

Computer Model of Blood Enzyme

Membrane-associated proteins play a vital role in a variety of cellular processes, yet little is known about the membrane-association mechanism. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is one such protein with an...

4.5 Million Euros in EU Funding for Saar…

This year, three computer scientists from Saarbrücken were awarded an "ERC Starting Grant" by the European Research Council. This award, endowed with 1.5 million euros each, is among the most...

2022 EU4Health Work Programme Adopted to…

Today the Commission has adopted the second EU4Health work programme. In 2022, the EU4Health will continue to invest in building stronger, more resilient health systems and pave the way for...

Five NHS Trusts in Surrey and Sussex to …

A consortium of NHS trusts that covers a population of circa 1.2 million will gain immediate access to important patient imaging, and will mobilise a regional workforce for patients, following...

Helping Cancer Patients Avoid Excessive …

A Case Western Reserve University-led team of scientists has used Artificial Intelligence (AI) to identify which patients with certain head and neck cancers would benefit from reducing the intensity of...

The Programme for the Union's Action in …

On 24 March 2021, Regulation (EU) 2021/522 of the European Parliament and of the Council1 was adopted as part of the Multiannual Financial Framework for the 2021-2027 period. That Regulation...

CliniSys Acquires HORIZON Lab Systems an…

CliniSys is announcing the recent acquisition of HORIZON Lab Systems and the combination with Sunquest Information Systems, as CliniSys. This acquisition and Sunquest combination creates one of the world’s...